Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
CA 2448102 A1 · Owner: Meyer, Sheryl L. · Inventors: Durkin, John T.; Angeles, Thelma S.; Spais, Chrysanthe M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides isolated mixed lineage kinase (7) (MLK) polynucleotides, expression vectors, host cells isolated polypeptides, methods of producing polypeptides isolated antibodies, compositions having the foregoing, methods for identifying a compound that binds a polypeptide or polynucleotide, and to methods for identifying a compound that modulates the activity of a poypeptide.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 23, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 23, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 23, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.